PEPTIDE LIBRARY

Synthetic peptide derived from human gastric juice. Known for tissue healing properties.

Synthetic fragment of Thymosin Beta-4 used for tissue repair and recovery.

Research peptide studied for wound healing and tissue regeneration.

Full-length thymosin protein for wound healing and cardiac tissue repair.

Naturally occurring tripeptide for tissue remodeling without the copper component.

Neurotrophic peptide mixture for neurological recovery. Approved outside the US.

Hydrolyzed collagen supplement for joint, skin, and connective tissue support.

Hydrolyzed elastin supplement for skin elasticity and vascular health.

Lipopeptide that signals collagen production for tissue repair and skin rejuvenation.

Copper-bound peptide complex for advanced wound healing and tissue remodeling.

Naturally occurring copper-binding peptide used in skincare for wound healing and anti-aging.

Topical peptide that reduces wrinkle depth by relaxing facial muscles.

Topical peptide for wrinkle reduction. Often called "Botox in a bottle."

Lipopeptide that stimulates collagen production for anti-aging skincare.

Collagen-stimulating lipopeptide for anti-aging skincare formulations.

Anti-inflammatory lipopeptide that reduces skin inflammaging.

Neuromuscular-targeting peptide for reducing expression lines topically.

Peptide that stimulates keratin production for hair and lash growth.

Biotin-peptide conjugate for strengthening hair follicle anchoring.

Selective GH secretagogue. Considered one of the safest GHRPs.

Synthetic GHRH analog that stimulates GH release from the pituitary.

Long-acting version of CJC-1295 with extended half-life via albumin binding.

FDA-approved GHRH analog for visceral fat reduction in HIV lipodystrophy.

Truncated GHRH analog. Previously FDA-approved for pediatric GH deficiency.

First-generation GH secretagogue. Strong GH release with significant appetite stimulation.

Most potent GHRP with strong GH release. Less hunger than GHRP-6.

Potent GHRP with unique cardioprotective properties via CD36 receptor binding.

Oral GH secretagogue (not technically a peptide). 24-hour GH elevation.

Stabilized GHRH fragment commonly paired with GHRPs for synergistic GH release.

Fat-burning fragment of HGH without anabolic or diabetogenic effects.

Early-generation growth hormone releasing peptide with moderate GH stimulation.

Synthetic GH secretagogue pentapeptide. Discontinued from clinical development.

FDA-approved oral GH secretagogue used as a diagnostic test for GH deficiency.

Oral non-peptide GH secretagogue. Development discontinued after Phase 2.

GLP-1 receptor agonist. FDA-approved for type 2 diabetes and weight management.

Dual GLP-1/GIP receptor agonist. FDA-approved for T2D and weight management.

Triple receptor agonist (GLP-1/GIP/Glucagon). Most potent weight loss peptide in trials.

GH fragment for fat metabolism. Does NOT produce typical HGH side effects.

Daily GLP-1 agonist. FDA-approved for both diabetes and weight management.

First GLP-1 agonist derived from Gila monster venom. FDA-approved for T2D.

Weekly GLP-1 agonist. FDA-approved for T2D with CV risk reduction.

Short-acting GLP-1 agonist focused on postprandial glucose control.

Dual GLP-1/glucagon agonist in late-stage trials for obesity and liver disease.

Anxiolytic peptide approved in Russia. Non-sedative, non-addictive.

Nootropic peptide approved in Russia. Enhances focus, memory, and neuroplasticity.

Potent nootropic that promotes synapse formation. No human trials.

Dipeptide-derived nootropic for memory and neuroprotection. Approved in Russia.

Neurogenic peptide that promotes hippocampal neurogenesis in research models.

NCAM-derived peptide that promotes synaptic plasticity and memory formation.

Bioregulatory tetrapeptide targeting cerebral cortex function.

Bioregulatory tripeptide targeting pineal gland and CNS function.

Antimicrobial peptide with broad-spectrum activity and wound healing properties.

Anti-inflammatory peptide fragment. Does NOT cause immunosuppression.

Thymic peptide for immune modulation. Approved in 35+ countries.

Immunomodulatory peptide used in mold illness (CIRS) protocols.

Zinc-dependent thymic peptide that promotes T-cell maturation and immune balance.

Thymic polypeptide that drives T-cell differentiation from bone marrow precursors.

Active pentapeptide fragment of thymopoietin for immune regulation.

Innate immune defense peptide with antimicrobial and chemotactic properties.

Bioactive peptide from milk protein with antimicrobial and immunomodulatory effects.

Precursor antimicrobial peptide of the innate immune system.

Telomerase activator studied for anti-aging effects on cellular lifespan.

Mitochondrial-derived peptide for metabolic regulation and exercise mimicry.

Mitochondrial-derived peptide with neuroprotective and metabolic effects.

Mitochondria-targeted peptide. FDA-approved for Barth syndrome.

NAD+ boosters for cellular energy, DNA repair, and longevity pathways.

Senolytic peptide that selectively eliminates senescent ("zombie") cells.

Sleep-promoting peptide that enhances deep sleep without suppressing REM.

Master antioxidant. Critical for detoxification, immune function, and cellular protection.

Anti-glycation dipeptide that protects proteins from age-related damage.

Thymic bioregulatory dipeptide for immune system rejuvenation.

Bioregulatory peptide targeting respiratory tissue repair and lung health.

Bioregulatory peptide for GI and respiratory mucosal tissue maintenance.

Liver-targeting bioregulatory peptide for hepatic cell renewal.

Pancreas-targeting bioregulatory peptide for beta cell support.

Testicular bioregulatory peptide for male reproductive health maintenance.

Prostate-targeting bioregulatory peptide for age-related prostate health.

FDA-approved for hypoactive sexual desire disorder. Works via brain pathways.

Tanning and sexual function peptide. Significant safety concerns.

Master regulator of reproductive hormones. Triggers natural GnRH release.

The "bonding hormone." FDA-approved for labor induction.

FDA-approved GnRH agonist. Maintains natural testosterone production on TRT.

Myostatin inhibitor for muscle growth research.

GnRH agonist for hormone suppression. FDA-approved for prostate cancer.

Intranasal GnRH agonist. FDA-approved for endometriosis and precocious puberty.

GnRH agonist for hormone suppression. Approved outside the US.

GnRH antagonist for rapid testosterone suppression without flare. FDA-approved.

NNMT inhibitor that boosts NAD+ for fat metabolism. Does not affect appetite.

AMPK activator known as an "exercise mimetic." Enhances endurance capacity.

Vascular-targeting peptide that destroys blood supply to fat tissue.

Triple monoamine reuptake inhibitor for appetite suppression and thermogenesis.

MC4R agonist for rare genetic obesity. FDA-approved for specific mutations.

GH receptor antagonist for acromegaly. Blocks excess growth hormone action.

Non-opioid intrathecal analgesic from cone snail venom. For severe chronic pain.

Gila monster venom peptide with emerging research in neuropathic pain.

Epitalon applied for cognitive and sleep-architecture benefits via pineal regulation.

BPC-157 applied for neuroprotective and dopamine-modulating cognitive support.

Selective mu-opioid receptor agonist peptide. Research tool only.

Generic name for PT-141. MC4R agonist for sexual desire disorders.

GHRP-2 approved in Japan as a diagnostic for GH deficiency.